Mental health medicines and drug-related deaths
A recent study of coronial inquest findings revealed medicines relating to mental health conditions (antidepressants, antipsychotics) were most commonly implicated in non-opioid and non-benzodiazepine...
Shifting gears: the pain specialist
Pene Wood is a dedicated pain, addiction and Quality Use of Medicines specialist who works across community pharmacy, policy and education. She has recently...
A founding hand in the Home Medicines Review
PSA 2026 Lifetime Achievement recipient Carlene Smith AM has shaped medicines management nationwide through her leadership in HMRs.
Pregabalin add-on for drug-resistant focal epilepsy
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1
Introduction
Approximately 3–3.5% of Australians will experience epilepsy at some point...
From the President: Onboard with aged care
Earlier this year the outgoing Federal Health Minister Greg Hunt announced the government would allocate $345.7 million in the 2022–23 federal Budget for pharmacists in aged care.
Patients and My Health Record
To opt out or not to opt out: what role does a pharmacist have in helping patients make informed decisions about My Health Record?
The...













